Jump to content Jump to main menu Jump to sub menu

Our Team

our_team

QED adamantly believes that our business and industry is not just all about numbers, it’s about people. After all, it’s people who invest their time and efforts in delivering clinical studies. It’s people who work in our corporate offices, manage and operate our business. It’s people who provide the services that our sponsors require. Ultimately, it’s people who go to work interacting with our customers all around the world. This is why at QED we recognise and value our people.

Our people are the heart of our organisation and the key to our success, which is why we place such great emphasis on their recruitment and retention. The QED team consists of specialised, highly experienced and motivated individuals who can guarantee first class results for our sponsors.

We have an impressive global team spanning the world, which includes Project Managers, Senior CRAs and CTAs, Regulatory and Safety Specialists, Data Managers and Biostatisticians. The quality of our personnel is crucial to our success. They are responsible for the high level of service we provide. So it is immensely important for us to motivate and retain our personnel.

QED Senior Management Team

Thomas Ogorka : Chief Executive Officer

As CEO, Thomas provides the vision and leadership which has been fundamental to QED’s growth since the company was founded in 2002. With over 15 years experience in the global pharmaceutical and CRO industry he has been able to build a wealth of knowledge and contacts in the industry. Prior to founding QED, Thomas has been involved in CRO consultancy activities and worked for one of the top 10 global CROs and for a global Central Laboratory at various Business Development levels.

Nazira Maruf : Director International Operations

As Director International Operations, Nazira is accountable for the successful delivery of International projects for QED. She also acts as operational relationship manager for both the client and QED partner CROs. With extensive experience in clinical research developed over 16 years in the pharmaceutical, freelance and CRO environments, Nazira joined QED in 2003 and has held various positions as the company has grown from Clinical Resource Manager, Head of Clinical Operations to her current position as Director International Operations.

Susan Ollier, HonFICR CSci : Director UK Operations

In her role as Director UK Operations, Susan is responsible for management of QED’s core clinical team and has oversight of all projects conducted within the UK. She is an Honorary Fellow of the Institute of Clinical Research (for which she served as Chair from 2007 to 2009), a Fellow of the Royal Society of Medicine, a Chartered Scientist and a Member of the British Association for Research Quality Assurance.　After studying Biological Sciences at Leicester University for her first degree, Susan worked in allergy research at St. Bartholomew’s Hospital, London for 11 years. During this time, she presented extensively at national and international conferences and symposia and has published 3 chapters and over 20 papers in the field of asthma and allergy.　In 1987, Susan moved from academia to the pharmaceutical industry, working initially with a small contract research company, establishing her own clinical research consultancy in 1993, which merged with QED Clinical Services Ltd in 2009.

Paul Thompson : Senior Director Global Sales & Marketing

As Senior Director Global Sales & Marketing, Paul is responsible for the definition of QED’s business development and marketing strategy to support the identification and procurement of global business and to drive growth of the company. Paul has over 10 years experience in business development and account management and joined QED in 2007. Prior to joining QED, Paul held positions of increasing responsibility within contracts, proposal and business development for a major CRO, over a period of 5 years. He has also worked successfully in an account management capacity for a US Fortune 500 major Information Technology corporation.